Featured Partnerships

Working in collaboration is one of our key values. Learn more about some our partnerships.

Tara Health and a collaborative of leading reproductive health foundations and investors are engaging the Camber Collective to map the landscape of the U.S. reproductive health market. We hope to better understand the sector’s most pressing needs and to identify areas for investment across asset classes that have a high potential to improve access to and quality of reproductive health products and services. 

 

Tara Health and the Foust/Meeker Team at Merrill Lynch have partnered to build a portfolio that is 100-percent aligned with the foundation’s mission. The portfolio comprises diverse asset classes, including public and private fixed income, public equities, mission-related hedge funds and private equity. Some of the investment management companies in the portfolio include Calvert, PAX World Investments, Neuberger Berman Funds, Wasmer, Schroeder & Company, Breckinridge Capital Advisors, TIAA Cref Global Asset Management and Ariel Asset Management. The Foust/Meeker Team at Merrill Lynch includes Mary K. Foust, Senior Vice President of Wealth Management, and Alena M. Meeker, First Vice President of Wealth Management.
Tara Health has partnered with Genentech to launch a multi-year research collaborative that will address innovative approaches to reducing long-term chronic disease. The collaborative includes the Center for Youth Wellness, the UCSF Benioff Children’s Hospital Oakland and the Bio-Core Bank at the University of California, San Francisco. This project will culminate in a randomized control trial to test and validate a screening tool for Adverse Childhood Experiences (ACE) in children. The study will also evaluate two separate primary care-based interventions and a panel of bio-markers, for children exposed to toxic stress. The study will help determine the potential impact of ACE screening on decreasing the risks for long-term chronic disease.